Khaw, C., Zablotska-Manos, I. & Boyd, M.A. Sex Res Soc Policy (2020). Abstract: Background Chemsex, the intentional combining of sex with the use of particular psychoactive substances typically crystal methamphetamine, gamma-hydroxybutyrate(GHB)/gamma butyrolactone(GBL), mephedrone, and ketamine has been reported among men who have sex with men (MSM). Chemsex is more common among MSM than in...
Welcome to the fresh new SASHA!
SHINE SA & SAMESH, 12th November 2020 Dear SASHA browsers, email subscribers, and occasional visitors, Welcome to our new-look SASHA (South Australian Sexual Health Awareness)! We hope you enjoy our fresh, updated web and email experience. Please read the following information to ensure the transition is as smooth as possible. SASHA is a current awareness service curated by a qualified and...
Digital chemsex support and care: The potential of just-in-time adaptive interventions
International Journal of Drug Policy, Volume 85, November 2020 T. Platteau, C. Herrijgers, J. de Wit Abstract Chemsex among gay, bisexual and other men who have sex with men (GBMSM) has received increasing attention as a public health concern in recent years. Chemsex can affect a variety of aspects of the lives of GBMSM and contribute to physical, social and emotional health burden. Starting from...
People identifying as LGBTIQ and alcohol, tobacco & other drugs in Australia
Australian Institute of Health and Welfare, last updated 12/06/2020 Key Findings: People identifying as lesbian, gay or bisexual have relatively high rates of substance use. However, there is a lack of comprehensive data available on the associated harms for this population group. Almost one in 5 (18.7%) people identifying as homosexual or bisexual reported daily tobacco smoking in 2016, comapred...
Australian Burden of Disease Study: Illicit Drug Use, Intimate Partner Violence, Unsafe Sex
Australian Institute of Health and Welfare, Last updated: 06 Aug 2020 Burden of disease is a measure of the years of healthy life lost from living with, or dying from disease and injury. A portion of this burden is preventable, being due to modifiable risk factors. This report provides information on the deaths and burden of disease due to risk factors included in the Australian Burden of...
Accessing pharmacotherapy (opioid replacement therapy) during COVID-19
Alcohol and Drug Foundation (Australia), April 27th 2020 There are now new challenges for people who access opioid replacement therapy (ORT) due to the COVID-19 (coronavirus) pandemic. Many may be experiencing anxiety and fear due to COVID-19 and trying to reduce and mitigate these feelings is vital. In most cases, people who are on ORT are required to visit their health clinic or pharmacy on a...